Search Results

There are 122693 results for: content related to: Reliability and validity of the direct observation clinical encounter examination (DOCEE)

  1. The long case and its modifications: a literature review

    Medical Education

    Volume 43, Issue 10, October 2009, Pages: 936–941, Gominda G Ponnamperuma, Indika M Karunathilake, Sean McAleer and Margery H Davis

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1365-2923.2009.03448.x

  2. You have free access to this content
    Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors

    International Journal of Cancer

    Volume 118, Issue 2, 15 January 2006, Pages: 396–404, Madhu Sudhan Shaik, Abhijit Chatterjee, Tanise Jackson and Mandip Singh

    Version of Record online : 28 JUL 2005, DOI: 10.1002/ijc.21325

  3. You have free access to this content
    The effect of Echinacea purpurea on the pharmacokinetics of docetaxel

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 467–474, Andrew K. L. Goey, Irma Meijerman, Hilde Rosing, Jacobus A. Burgers, Marja Mergui-Roelvink, Marianne Keessen, Serena Marchetti, Jos H. Beijnen and Jan H. M. Schellens

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12159

  4. Challenging Beliefs, Practices, and Content: How Museum Educators Change

    Science Education

    Volume 98, Issue 1, January 2014, Pages: 84–105, LAUREN B. ALLEN and KEVIN J. CROWLEY

    Version of Record online : 25 NOV 2013, DOI: 10.1002/sce.21093

  5. You have full text access to this Open Access content
    Predictive factors for response to docetaxel in human breast cancers

    Cancer Science

    Volume 97, Issue 9, September 2006, Pages: 813–820, Shinzaburo Noguchi

    Version of Record online : 29 JUN 2006, DOI: 10.1111/j.1349-7006.2006.00265.x

  6. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  7. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  8. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  9. Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer

    Veterinary and Comparative Oncology

    Volume 12, Issue 2, June 2014, Pages: 160–168, A. Waite, C. Balkman, D. Bailey, M. Kiselow, A. Flory, B. B. Beaulieu, L. D. Lewis and M. McEntee

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1476-5829.2012.00350.x

  10. You have free access to this content
    Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel

    International Journal of Cancer

    Volume 125, Issue 11, 1 December 2009, Pages: 2728–2736, Lysann Sauer, Joao Nunes, Vishal Salunkhe, Lenka Skalska, Takafumi Kohama, Olivier Cuvillier, Jonathan Waxman and Dmitry Pchejetski

    Version of Record online : 11 JUN 2009, DOI: 10.1002/ijc.24640

  11. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer

    The Prostate

    Volume 70, Issue 13, 15 September 2010, Pages: 1437–1447, Alain G. Musende, Andy Eberding, William Jia, Euan Ramsay, Marcel B. Bally and Emma Tomlinson Guns

    Version of Record online : 28 APR 2010, DOI: 10.1002/pros.21179

  12. You have free access to this content
    Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models

    International Journal of Cancer

    Volume 125, Issue 11, 1 December 2009, Pages: 2711–2720, Gongjie Liu, Stacey A. Taylor, Cindy H. Marrinan, Yunsheng Hsieh, W. Robert Bishop, Paul Kirschmeier and Brian J. Long

    Version of Record online : 15 JUN 2009, DOI: 10.1002/ijc.24644

  13. You have free access to this content
    Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel

    International Journal of Cancer

    Volume 136, Issue 1, 1 January 2015, Pages: 225–233, Dilek Iusuf, Jeroen J.M.A. Hendrikx, Anita van Esch, Evita van de Steeg, Els Wagenaar, Hilde Rosing, Jos H. Beijnen and Alfred H. Schinkel

    Version of Record online : 3 JUN 2014, DOI: 10.1002/ijc.28970

  14. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  15. You have free access to this content
    Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer

    International Journal of Cancer

    Volume 122, Issue 9, 1 May 2008, Pages: 1941–1948, Edward W. Howard, Davy T. Lee, Yung Tuen Chiu, Chee Wai Chua, Xianghong Wang and Yong Chuan Wong

    Version of Record online : 8 JAN 2008, DOI: 10.1002/ijc.23355

  16. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  17. Amplification loop cascade for increasing caspase activity induced by docetaxel

    Journal of Cellular Biochemistry

    Volume 96, Issue 4, 1 November 2005, Pages: 810–820, Dongxu Cao, Bin Qiao, Zhiqiang Ge and Yingjin Yuan

    Version of Record online : 7 SEP 2005, DOI: 10.1002/jcb.20563

  18. Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations

    The Journal of Clinical Pharmacology

    Nour Al Faqeer, Ola Mashni, Rawan Dawoud, Asma Rumman, Esraa Hanoun and Lama Nazer

    Version of Record online : 23 AUG 2016, DOI: 10.1002/jcph.803

  19. Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

    International Journal of Cancer

    Volume 138, Issue 3, 1 February 2016, Pages: 758–769, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Ji-Ying Song, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Sven Rottenberg and Alfred H. Schinkel

    Version of Record online : 21 SEP 2015, DOI: 10.1002/ijc.29812

  20. You have free access to this content
    Capecitabine plus docetaxel combination therapy

    Cancer

    Volume 103, Issue 12, 15 June 2005, Pages: 2455–2465, Shailendra Verma, Dominique Maraninchi, Joyce O'Shaughnessy, Carol Jamieson, Stephen Jones, Miguel Martín, Joseph McKendrick, David Miles, Chris Twelves and John Hornberger

    Version of Record online : 12 MAY 2005, DOI: 10.1002/cncr.21122